Joseph L. Goldstein

Insider Reports History

Entity
Individual
Location
Dept Of Pharmacology K5 Yuver Of Texas, 5323 Harry Hines Blvd, Dallas, Texas
Signature
/s/**Joseph L. Goldstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph L. Goldstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 6,382 $6.07 M $951.26 Jan 23, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 0 Jan 23, 2024 Direct

Insider Reports Filed by Joseph L. Goldstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Jan 23, 2024 3 -878,151 4 Jan 25, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 2 0 4 Jan 4, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 6, 2023 3 -1,146,477 4 Feb 8, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 2 0 4 Jan 5, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 30, 2022 3 -792,214 4 Apr 1, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2022 2 0 4 Jan 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 10, 2021 3 -666,975 4 Sep 13, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 7, 2021 3 -291,198 4 Jun 8, 2021 Director